| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Hepion Pharmaceuticals, Inc.
13D/A
Amendment 1
HEPA · 426897401
|
26.2% |
8/20/2026
Event 8/3/2026
|
|||
| Gravitas Capital LP | 21.4% | ||||
| Invictus Capital Advisors Pension Plan | 5.7% | ||||
| Vincent LoPriore | 26.2% | ||||
|
Hepion Pharmaceuticals, Inc.
13D
HEPA · 426897401
|
21.5% |
5/1/2026
Event 4/21/2026
|
|||
| Gravitas Capital LP | 17.2% | ||||
| Invictus Capital Advisors Pension Plan | 4.3% | ||||
| Vincent LoPriore | 21.5% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.